These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22166455)

  • 1. Neuroimaging in Parkinson's disease: from pathology to diagnosis.
    Stoessl AJ
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional imaging in Parkinson disease.
    Nandhagopal R; McKeown MJ; Stoessl AJ
    Neurology; 2008 Apr; 70(16 Pt 2):1478-88. PubMed ID: 18413571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging neurodegeneration in Parkinson's disease.
    Pavese N; Brooks DJ
    Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET and SPECT functional imaging in Parkinson's disease.
    Antonini A; DeNotaris R
    Sleep Med; 2004 Mar; 5(2):201-6. PubMed ID: 15033144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SPECT and PET in Parkinson's disease].
    Matsuda H
    Nihon Rinsho; 2000 Oct; 58(10):2000-6. PubMed ID: 11068438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.
    Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A
    Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments of brain imaging for Parkinson's disease and related disorders.
    Piccini P; Brooks DJ
    Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging: current role in detecting pre-motor Parkinson's disease.
    Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K
    Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nuclear medicine imaging in neurodegenerative dementias].
    Gratz S; Hahn U; Kaiser JW; Jarnig M; Schwarz J; Förstl H
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S5-7. PubMed ID: 18437639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET and SPECT in Parkinson's disease].
    Blesa R
    Rev Neurol; 1997 Aug; 25 Suppl 2():S147-50. PubMed ID: 9280681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging in Parkinson's disease.
    Stoessl AJ
    Neurotherapeutics; 2011 Jan; 8(1):72-81. PubMed ID: 21274687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging approaches to Parkinson disease.
    Brooks DJ
    J Nucl Med; 2010 Apr; 51(4):596-609. PubMed ID: 20351351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of magnetic resonance imaging (MRI) and single photon emission computing tomography (SPECT) for the differential diagnosis of Parkinson's disease and other neurodegenerative disorders presenting as parkinsonism].
    Kohira I
    Nihon Rinsho; 1997 Jan; 55(1):39-42. PubMed ID: 9014421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
    Marek K; Jennings D; Tamagnan G; Seibyl J
    Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging over the course of Parkinson's disease: from early detection of the at-risk patient to improving pharmacotherapy of later-stage disease.
    Seibyl J; Russell D; Jennings D; Marek K
    Semin Nucl Med; 2012 Nov; 42(6):406-14. PubMed ID: 23026362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we image premotor Parkinson disease?
    Marek K; Jennings D
    Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
    Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
    Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.